Biotechnology Stocks I Performance Guide: Beam Therapeutics Inc. (BEAM)
BEAM has no dividends.
Table and Chart of BEAM Performance
See what a $1,000 investment in BEAM is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| BEAM Returns | |
|---|---|
| Start Date | Mar-31-2020 |
| Start Price | $18.00 |
| End Date | May-08-2024 |
| End Price | $22.24 |
| # Prices | 51 |
| Min Date | Apr-30-2020 |
| Min Price | $15.95 |
| Max Date | Jun-30-2021 |
| Max Price | $128.71 |
| Total Return | 23.56% |
| Annualized Return | 5.10% |
| Current Value of $1,000 Purchase | $1,236 |
| Number Returns | 1,275 |
| Average Return | 14.75% |
| Number Profitable Returns | 456 |
| Percent Profitable Returns | 35.76% |
| Number Unprofitable Returns | 819 |
| Percent Unprofitable Returns | 64.24% |
| Profitable to Unprofitable Returns Ratio | 0.56 |
| BEAM Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $1,854,469,000 |
| Beta | 1.768 | Price to Sales | 5.61 |
| Earnings per Share | $-1.7200 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 2.158 |
| PRICE DATA | |
| 52 Week High | $49.5 |
| 52 Week Low | $16.95 |
| Analyst Target Price | $50 |
| 50-Day Moving Average | $30.51 |
| 200-Day Moving Average | $26.99 |
| FINANCIAL DATA | |
| Revenue per Share | $4.896 |
| Revenue | $377,709,000 |
| Profit Margin | -35.1% |
| Return on Equity | -15.5% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
BEAM Compare Returns with S&P 500
BEAM Trendline Chart
BEAM Moving Average Chart
BEAM Stock Return Map - See Patterns of Gains and Losses
BEAM Stock Returns/Purchase Dates